DK2120991T3 - Behandling af traumatisk blødning med korte oligopeptider - Google Patents
Behandling af traumatisk blødning med korte oligopeptiderInfo
- Publication number
- DK2120991T3 DK2120991T3 DK08712603.3T DK08712603T DK2120991T3 DK 2120991 T3 DK2120991 T3 DK 2120991T3 DK 08712603 T DK08712603 T DK 08712603T DK 2120991 T3 DK2120991 T3 DK 2120991T3
- Authority
- DK
- Denmark
- Prior art keywords
- olegopeptides
- short
- treatment
- traumatic bleeding
- traumatic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/525—Tumor necrosis factor [TNF]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/52—Assays involving cytokines
- G01N2333/54—Interleukins [IL]
- G01N2333/5412—IL-6
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Endocrinology (AREA)
- Pathology (AREA)
- Reproductive Health (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US90115507P | 2007-02-12 | 2007-02-12 | |
US96184107P | 2007-07-23 | 2007-07-23 | |
PCT/NL2008/050077 WO2008100140A1 (en) | 2007-02-12 | 2008-02-11 | Treatment of trauma hemorrhage with short oligopeptides |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2120991T3 true DK2120991T3 (da) | 2014-04-28 |
Family
ID=39493380
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK08712603.3T DK2120991T3 (da) | 2007-02-12 | 2008-02-11 | Behandling af traumatisk blødning med korte oligopeptider |
Country Status (12)
Country | Link |
---|---|
US (1) | US20080267936A1 (da) |
EP (1) | EP2120991B1 (da) |
AU (1) | AU2008215193B2 (da) |
CA (1) | CA2677948C (da) |
DK (1) | DK2120991T3 (da) |
ES (1) | ES2456333T3 (da) |
HK (1) | HK1137342A1 (da) |
NZ (1) | NZ578956A (da) |
PL (1) | PL2120991T3 (da) |
PT (1) | PT2120991E (da) |
SG (1) | SG178780A1 (da) |
WO (1) | WO2008100140A1 (da) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030220258A1 (en) * | 2001-12-21 | 2003-11-27 | Robbert Benner | Treatment of ischemic events |
US7358330B2 (en) | 2001-03-29 | 2008-04-15 | Biotempt B.V. | Immunoregulatory compositions |
US7517529B2 (en) * | 2003-04-08 | 2009-04-14 | Biotempt B.V. | Treatment of type I diabetes |
EP1864692A1 (en) | 2006-06-07 | 2007-12-12 | Biotempt B.V. | Use of peptides for the control of radiation injury |
US11026970B2 (en) | 2017-05-19 | 2021-06-08 | Hemanext Inc. | Methods and treatment of trauma adverse events with oxygen reduced blood |
MX2022003820A (es) * | 2019-09-30 | 2022-09-19 | Ebi Anti Sepsis B V | Metodos de tratamiento para modificar la hermodinamica. |
US20240016882A1 (en) * | 2020-09-30 | 2024-01-18 | Biotempt B.V. | Autophagy-inhibiting peptide and organic acid salt thereof addressing issues of vascular permeability |
Family Cites Families (83)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2360794C2 (de) * | 1973-12-06 | 1984-12-06 | Hoechst Ag, 6230 Frankfurt | Verfahren zur Herstellung von Peptiden |
US4108846A (en) * | 1977-02-01 | 1978-08-22 | Hoffmann-La Roche Inc. | Solid phase synthesis with base N alpha-protecting group cleavage |
JPS5822474B2 (ja) * | 1980-06-10 | 1983-05-09 | 天野製薬株式会社 | コレシストキニン・パンクレオザイミンc端ペプチドアミドスルフエ−トエステルの製造法 |
US4351762A (en) * | 1981-03-10 | 1982-09-28 | Bioresearch, Inc. | Rapid, quantitative peptide synthesis using mixed anhydrides |
US4427660A (en) * | 1982-03-03 | 1984-01-24 | Research Corporation | Formyl-methionyl chemotatic peptide antibiotic conjugates useful in treating infections |
US4571336A (en) * | 1983-08-25 | 1986-02-18 | Endorphin, Inc. | Immune stimulation |
US4855285A (en) * | 1985-12-04 | 1989-08-08 | The Ohio State University Research Foundation | Antigenic modification of polypeptides |
US4753965A (en) * | 1987-04-09 | 1988-06-28 | Merrell Dow Pharmaceuticals, Inc. | Method of treating multiple sclerosis with chalcone derivatives |
US5002961A (en) * | 1987-10-19 | 1991-03-26 | Merrell Dow Pharmaceuticals | Method for reducing injury with imidazol-2-thionecarboxamides |
US4966848A (en) * | 1988-02-08 | 1990-10-30 | The General Hospital Corporation | Isolation, purification, characterization, cloning and sequencing of N α-acetyltransferase |
US5010175A (en) * | 1988-05-02 | 1991-04-23 | The Regents Of The University Of California | General method for producing and selecting peptides with specific properties |
ATE136551T1 (de) * | 1988-05-10 | 1996-04-15 | Alpha 1 Biomedicals Inc | Festphase-verfahren zur gewinnung von thymosin- alpha-1 |
US5055447A (en) * | 1988-07-28 | 1991-10-08 | Genentech, Inc. | Method and compositions for the treatment and prevention of septic shock |
US5308834A (en) * | 1989-02-14 | 1994-05-03 | Incyte Pharmaceuticals, Inc. | Treatment of endotoxin-associated shock and prevention thereof using a BPI protein |
US5102393A (en) * | 1989-07-17 | 1992-04-07 | Survival Technology, Inc. | Autoinjector converted from intramuscular to subcutaneous mode of injection |
US5223421A (en) * | 1989-10-25 | 1993-06-29 | The General Hospital Corporation | Identification of methionine Nα-acetyltransferase |
US6051596A (en) * | 1990-08-10 | 2000-04-18 | Anormed, Inc. | Immunosuppressive compositions |
US5958413A (en) * | 1990-11-01 | 1999-09-28 | Celltech Limited | Use of antibodies to TNF or fragments derived thereof and xanthine derivatives for combination therapy and compositions therefor |
US5200507A (en) * | 1991-04-12 | 1993-04-06 | Mallinckrodt Specialty Chemicals Company | Method of separating a peptide from a resin |
US5223397A (en) * | 1991-06-05 | 1993-06-29 | Sangstat Medical Corporation | Soluble hla cross-match |
ATE152734T1 (de) * | 1992-05-30 | 1997-05-15 | Sikiric Predrag | Bpc-peptide, deren herstellung und verwendung |
US5436270A (en) * | 1993-04-07 | 1995-07-25 | National Science Council | Method for protecting against endotoxin-induced shock |
US5380668A (en) * | 1993-07-06 | 1995-01-10 | University Of Utah Research Foundation | Compounds having the antigenicity of hCG |
NZ278607A (en) * | 1994-02-07 | 1999-05-28 | Knoll Ag | Use of tnf antagonists for treating disorders involving elevated serum levels of il-6 wherein the serum levels are 500pg/ml or above |
US5807746A (en) * | 1994-06-13 | 1998-09-15 | Vanderbilt University | Method for importing biologically active molecules into cells |
US5677275A (en) * | 1994-08-05 | 1997-10-14 | The United States Of America As Represented By The Department Of Health And Human Services | Treatment of cancer with human chorionic gonadotropin |
SE520730C2 (sv) * | 1995-01-20 | 2003-08-19 | Eskil Elmer | Behandling av hjärnischemi och hjärnskador med ett neuroprotektivt läkemedel |
WO1996033218A1 (en) * | 1995-04-21 | 1996-10-24 | Allelix Biopharmaceuticals Inc. | Anti-haemorrhagic peptides |
US5942494A (en) * | 1995-10-06 | 1999-08-24 | The Trustees Of Columbia University In The City Of New York | Stimulation of gene expression and synthesis of heat shock protein 72/73 (HSP 70) |
US5912014A (en) * | 1996-03-15 | 1999-06-15 | Unigene Laboratories, Inc. | Oral salmon calcitonin pharmaceutical products |
US6361992B1 (en) * | 1996-05-08 | 2002-03-26 | The United States Of America As Represented By The Department Of Health And Human Services | Thyroid stimulating hormone superagonists |
US6207145B1 (en) * | 1997-05-09 | 2001-03-27 | Pharma Pacific Pty Ltd. | Therapeutic applications of high dose interferon |
US6319504B1 (en) * | 1996-06-24 | 2001-11-20 | University Of Maryland Biotechnology Institute | Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin |
US5968513A (en) * | 1996-06-24 | 1999-10-19 | University Of Maryland Biotechnology Institute | Method of promoting hematopoiesis using derivatives of human chorionic gonadotropin |
GB9617021D0 (en) * | 1996-08-13 | 1996-09-25 | Salpep Biotechnology Inc | Novel peptides for treatment of inflammation and shock |
GB9624927D0 (en) * | 1996-11-29 | 1997-01-15 | Oxford Glycosciences Uk Ltd | Gels and their use |
US5966712A (en) * | 1996-12-12 | 1999-10-12 | Incyte Pharmaceuticals, Inc. | Database and system for storing, comparing and displaying genomic information |
EP0979096B1 (en) * | 1997-02-15 | 2003-05-14 | Millennium Pharmaceuticals, Inc. | Treatment of infarcts through inhibition of nf-kappab |
US6416959B1 (en) * | 1997-02-27 | 2002-07-09 | Kenneth Giuliano | System for cell-based screening |
EP1435519B1 (en) * | 1997-04-07 | 2007-02-14 | Fisher BioImage ApS | A method for screening substances for effect on cAMP levels based on intracellular translocation of PKA |
US5801193A (en) * | 1997-04-15 | 1998-09-01 | Immune Modulation, Inc. | Compositions and methods for immunosuppressing |
US6583109B1 (en) * | 1997-06-24 | 2003-06-24 | Robert C. Gallo | Therapeutic polypeptides from β-hCG and derivatives |
US6075150A (en) * | 1998-01-26 | 2000-06-13 | Cv Therapeutics, Inc. | α-ketoamide inhibitors of 20S proteasome |
US6022696A (en) * | 1998-04-02 | 2000-02-08 | Washington State University Research Foundation | Methods of identifying agonists or antagonists of angiotensin IV |
US7175679B2 (en) * | 2001-03-29 | 2007-02-13 | Biotempt B.V. | Oligopeptide treatment of NF-κB mediated inflammation |
US6844315B2 (en) * | 1998-05-20 | 2005-01-18 | Erasmus Universiteit Rotterdam | Immunoregulator |
US8680059B2 (en) * | 1998-05-20 | 2014-03-25 | Biotempt B.V. | Oligopeptide acetate and formulations thereof |
US20050227925A1 (en) * | 2004-04-08 | 2005-10-13 | Robbert Benner | Compositions capable of reducing elevated blood urea concentration |
US20040202645A1 (en) * | 2003-04-08 | 2004-10-14 | Khan Nisar Ahmed | Administration of gene-regulatory peptides |
EP1138692A1 (en) * | 2000-03-29 | 2001-10-04 | Erasmus Universiteit Rotterdam | Fragments of human chorionic gonadotropin (hcg) as immunoregulator |
US20030220258A1 (en) * | 2001-12-21 | 2003-11-27 | Robbert Benner | Treatment of ischemic events |
US6921751B1 (en) * | 1998-05-20 | 2005-07-26 | Erasmus Universiteit Rotterdam | Immunoregulator |
US20090042807A1 (en) * | 1998-05-20 | 2009-02-12 | Nisar Ahmed Khan | Oligopeptide treatment of ischemia reperfusion injury |
CA2329274A1 (en) * | 1998-05-29 | 1999-12-02 | Steven M. Ruben | Interleukin-21 |
US6507788B1 (en) * | 1999-02-25 | 2003-01-14 | Société de Conseils de Recherches et D'Applications Scientifiques (S.C.R.A.S.) | Rational selection of putative peptides from identified nucleotide, or peptide sequences, of unknown function |
US20030148955A1 (en) * | 1999-04-19 | 2003-08-07 | Pluenneke John D. | Soluble tumor necrosis factor receptor treatment of medical disorders |
US6379970B1 (en) * | 1999-04-30 | 2002-04-30 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Analysis of differential protein expression |
RU2157233C1 (ru) * | 1999-05-11 | 2000-10-10 | Санкт-Петербургская общественная организация "Институт биорегуляции и геронтологии" | Тетрапептид, обладающий геропротекторной активностью, фармакологическое средство на его основе и способ его применения |
US7994278B1 (en) * | 1999-08-06 | 2011-08-09 | Nobel Biosciences Llc | Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA) |
US7576174B2 (en) * | 2000-03-29 | 2009-08-18 | Biotempt B.V. | Compositions capable of reducing elevated blood urea concentration |
US7358330B2 (en) * | 2001-03-29 | 2008-04-15 | Biotempt B.V. | Immunoregulatory compositions |
US20050037430A1 (en) * | 2000-03-29 | 2005-02-17 | Biotempt B.V. | Methods and uses for protein breakdown products |
EP1300418A1 (en) * | 2001-10-04 | 2003-04-09 | Erasmus Universiteit Rotterdam | Gene regulation by oligopeptides |
US6783757B2 (en) * | 2000-06-01 | 2004-08-31 | Kirkman Group, Inc. | Composition and method for increasing exorphin catabolism to treat autism |
US6539102B1 (en) * | 2000-09-01 | 2003-03-25 | Large Scale Proteomics | Reference database |
EP1217540A1 (en) * | 2000-11-29 | 2002-06-26 | Lafayette Software Inc. | Methods of organizing data and processing queries in a database system, and database system and software product for implementing such method |
US7316819B2 (en) * | 2001-03-08 | 2008-01-08 | Unigene Laboratories, Inc. | Oral peptide pharmaceutical dosage form and method of production |
US6894028B2 (en) * | 2001-04-06 | 2005-05-17 | Zengen, Inc. | Use of KPV tripeptide for dermatological disorders |
US7368535B2 (en) * | 2001-05-24 | 2008-05-06 | Trillium Therapeutics Inc. | CD200 receptors |
US20040072246A1 (en) * | 2001-09-11 | 2004-04-15 | Roland Martin | System and method for identifying t cell and other epitopes and the like |
US20080194489A1 (en) * | 2001-12-21 | 2008-08-14 | Khan Nisar A | Treatment of iatrogenic disease |
US7786084B2 (en) * | 2001-12-21 | 2010-08-31 | Biotempt B.V. | Treatment of burns |
US20040013661A1 (en) * | 2001-12-21 | 2004-01-22 | Gert Wensvoort | Stratification |
US7501391B2 (en) * | 2001-12-21 | 2009-03-10 | Biotempt B.V. | Treatment of transplant survival |
US7560433B2 (en) * | 2001-12-21 | 2009-07-14 | Biotempt B.V. | Treatment of multiple sclerosis (MS) |
EP1581556A2 (en) * | 2002-08-15 | 2005-10-05 | Leukotech A/S | Bactericidal, anti-apoptotic, pro-inflammatory and anti-inflammatory peptides of heparin-binding protein (hbp) |
EP1466612A1 (en) * | 2003-04-08 | 2004-10-13 | Biotempt B.V. | Treatment of inflammation and sepsis with hCG derived peptides |
US7517529B2 (en) * | 2003-04-08 | 2009-04-14 | Biotempt B.V. | Treatment of type I diabetes |
IL157772A (en) * | 2003-09-04 | 2016-06-30 | Bmr Solutions Ltd | Compounds containing oligopeptide derived from turtle larvae and their use to encourage mammalian hemophysis |
US6856403B1 (en) * | 2003-09-11 | 2005-02-15 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Optically stimulated electron emission contamination monitor and method |
US20090227505A1 (en) * | 2004-01-07 | 2009-09-10 | Biotempt B.V. | Methods and uses for protein breakdown products |
AU2006266609C1 (en) * | 2005-07-05 | 2011-10-27 | Biotempt B.V. | Treatment of tumors |
EP1864692A1 (en) * | 2006-06-07 | 2007-12-12 | Biotempt B.V. | Use of peptides for the control of radiation injury |
-
2008
- 2008-02-11 NZ NZ578956A patent/NZ578956A/en unknown
- 2008-02-11 SG SG2012009809A patent/SG178780A1/en unknown
- 2008-02-11 ES ES08712603.3T patent/ES2456333T3/es active Active
- 2008-02-11 EP EP08712603.3A patent/EP2120991B1/en active Active
- 2008-02-11 WO PCT/NL2008/050077 patent/WO2008100140A1/en active Application Filing
- 2008-02-11 DK DK08712603.3T patent/DK2120991T3/da active
- 2008-02-11 AU AU2008215193A patent/AU2008215193B2/en active Active
- 2008-02-11 PL PL08712603T patent/PL2120991T3/pl unknown
- 2008-02-11 PT PT87126033T patent/PT2120991E/pt unknown
- 2008-02-11 CA CA2677948A patent/CA2677948C/en active Active
- 2008-02-12 US US12/069,741 patent/US20080267936A1/en not_active Abandoned
-
2010
- 2010-01-29 HK HK10101069.2A patent/HK1137342A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP2120991B1 (en) | 2014-01-29 |
NZ578956A (en) | 2012-02-24 |
EP2120991A1 (en) | 2009-11-25 |
AU2008215193B2 (en) | 2014-01-16 |
US20080267936A1 (en) | 2008-10-30 |
CA2677948C (en) | 2014-12-09 |
HK1137342A1 (en) | 2010-07-30 |
AU2008215193A1 (en) | 2008-08-21 |
SG178780A1 (en) | 2012-03-29 |
ES2456333T3 (es) | 2014-04-22 |
PT2120991E (pt) | 2014-05-02 |
CA2677948A1 (en) | 2008-08-21 |
WO2008100140A1 (en) | 2008-08-21 |
PL2120991T3 (pl) | 2014-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2982696T3 (da) | Behandling af akut lymfoblastær leukæmi | |
DK2084174T3 (da) | Fremstilling af ribofuranosylpyrimidinnukleotider | |
DK1986633T3 (da) | Behandling af duchennes muskeldystrofi | |
DK2144923T3 (da) | Behandlingsfremgangsmåder under anvendelse af glycopegyleret g-csf | |
DK2041270T3 (da) | Fremstilling af glycoproteiner | |
DK3296284T3 (da) | Ikke-terapeutisk anvendelse af hydroxybutyratester | |
DK2219469T3 (da) | Modificering af enzymatisk disponerede proteiner | |
DK2350116T3 (da) | Behandling af biofilm | |
FR2941143B1 (fr) | Agrafe chirurgicale auto-agrippante | |
DK1976516T3 (da) | Behandling af viral hepatitis | |
BRPI0811265A2 (pt) | Tratamento de sinucleinopatias | |
DK2318396T3 (da) | Krystalform af posaconazol | |
DK2211901T3 (da) | Vaccination med multiple clader af h5-influenza-a-virus | |
DK2111555T3 (da) | Diagnosticering af præeklampsi | |
DK3175863T3 (da) | Varianter af c-type natriuretisk peptid | |
DK2300560T3 (da) | Termisk behandling af biomasse | |
DK2262793T3 (da) | Krystallinske former af nilotinib-hci | |
DK2222272T3 (da) | Behandling af luftvejssygdom | |
DK2358714T3 (da) | Alkylcyclohexylethere af dihydrotetraazabenzoazulener | |
DK2254591T3 (da) | Inhibering eller behandling af gastrointestinal biofilm | |
DK2260873T3 (da) | Pcylering af proteiner | |
BRPI0821342A2 (pt) | inibidores da polimerase viral | |
DK2364166T3 (da) | Undertrykkelse af cancer | |
DK2411009T3 (da) | Terapeutiske anvendelser af quinazolindionderivater | |
DK2178900T3 (da) | Oprensning af pegylerede polypeptider |